Native Human Vitronectin (VTN) protein (>90%), Human plasma, LYOPH (CAT#: GP01-136J)

Product Overview	Human Vitronectin (VTN) protein (NP_000629) was isolated from Human plasma. The biological activity was determined by its binding ability in a functional ELISA. This product can be used in ELISA.
Biological Activity	Determined by its binding ability in a functional ELISA.
Source	Human plasma
Species	Human
Predicted MW	75 KDa
Purity	>90%, determined by SDS-PAGE and HPLC
Conjugation	Unconjugated

Target	VTN
Full Name	Vitronectin
Gene ID	7448
Uniprot ID	P04004
Accession Number	NP_000629
Background	The protein encoded by this gene functions in part as an adhesive glycoprotein. Differential expression of this protein can promote either cell adhesion or migration as it links cells to the extracellular matrix through a variety of ligands. These ligands include integrins, plasminogen activator inhibitor-1, and urokinase plasminogen activator receptor. This secreted protein can be present in the plasma as a monomer or dimer and forms a multimer in the extracellular matrix of several tissues. This protein also inhibits the membrane-damaging effect of the terminal cytolytic complement pathway and binds to several serpin serine protease inhibitors. This protein can also promote extracellular matrix degradation and thus plays a role in tumorigenesis. It is involved in a variety of other biological processes such as the regulation of the coagulation pathway, wound healing, and tissue remodeling. The heparin-binding domain of this protein give it anti-microbial properties. It is also a lipid binding protein that forms a principal component of high density lipoprotein.
Alternate Names	VN; V75; VNT; Vitronectin